Curcumin and Diabetes: A Systematic Review

Dongwei Zhang(Beijing University of Chinese Medicine), Min Fu(McGill University Health Centre), Gao S(Beijing University of Chinese Medicine), Jun‐Li Liu(McGill University Health Centre)
Evidence-based Complementary and Alternative Medicine
January 1, 2013
Cited by 373Open Access
Full Text

Abstract

Turmeric (Curcuma longa), a rhizomatous herbaceous perennial plant of the ginger family, has been used for the treatment of diabetes in Ayurvedic and traditional Chinese medicine. The active component of turmeric, curcumin, has caught attention as a potential treatment for diabetes and its complications primarily because it is a relatively safe and inexpensive drug that reduces glycemia and hyperlipidemia in rodent models of diabetes. Here, we review the recent literature on the applications of curcumin for glycemia and diabetes-related liver disorders, adipocyte dysfunction, neuropathy, nephropathy, vascular diseases, pancreatic disorders, and other complications, and we also discuss its antioxidant and anti-inflammatory properties. The applications of additional curcuminoid compounds for diabetes prevention and treatment are also included in this paper. Finally, we mention the approaches that are currently being sought to generate a "super curcumin" through improvement of the bioavailability to bring this promising natural product to the forefront of diabetes therapeutics.


Related Papers

No related papers found

Powered by citation graph analysis